Dr Sarbendra Pradhananga
Clinical Medicine, School of Medicine and Population Health
Postdoctoral Research Associate
S.L.Pradhananga@sheffield.ac.uk
The Medical School
Full contact details
Dr Sarbendra Pradhananga
Clinical Medicine, School of Medicine and Population Health
The Medical School
Beech Hill Road
Sheffield
S10 2RX
Clinical Medicine, School of Medicine and Population Health
The Medical School
Beech Hill Road
Sheffield
S10 2RX
- Publications
-
Show: Featured publications All publications
Featured publications
This person does not have any publications available.
All publications
Journal articles
- A long-acting GH receptor antagonist through fusion to GH binding protein.. Scientific Reports, 6. View this article in WRRO
- OR5-3: A GH antagonist fusion with GH binding protein is biologically active, shows delayed clearance and inhibits growth in a rabbit model. Growth Hormone & IGF Research, 24, S14-S15.
- Ligand-Receptor Fusion Dimers, 227-235.
- P02-27 Challenges encountered in the development of an in vivo mouse model system for testing growth hormone antagonist molecules. Growth Hormone & IGF Research, 22, S63-S63.
- OR03-1 Development of a platform technology to generate long-acting protein therapeutics. Growth Hormone & IGF Research, 22, S6-S7.
- Biologics, biosimilars and biobetters in protein hormone therapy: Natural synthesis. Biochemist, 34(1), 10-15.
- Immunogenicity, toxicology, pharmacokinetics and pharmacodynamics of growth hormone ligand-receptor fusions.. Clin Sci (Lond), 119(11), 483-491.
- A ligand-receptor fusion of growth hormone forms a dimer and is a potent long-acting agonist.. Nat Med, 13(9), 1108-1113.
- Pegvisomant: structure and function. Journal of Molecular Endocrinology, 29(1), 11-14.
- Sensitivity of L-2 type beta-lactamases from Stenotrophomonas maltophilia to serine active site beta-lactamase inhibitors.. J Antimicrob Chemother, 37(2), 394-396.
Chapters
- Long-Acting Growth Hormone Analogues, Growth Hormone Related Diseases and Therapy (pp. 361-373). Humana Press
Conference proceedings papers
- A long-acting GH receptor antagonist through fusion to GH binding protein.. Scientific Reports, 6. View this article in WRRO